All Stories

  1. Vascular Access-Related Heart Failure
  2. Kidney health without borders: a multilingual kidney education platform
  3. A journey through veins: discovery to modern therapy
  4. Green Dialysis –Water Conservation Program in Hemodialysis Units
  5. Building Interventional Nephrology Skills in India: A Decade-Long Journey by the AVATAR Foundation
  6. Maximizing use of available vascular capital for autologous arteriovenous fistula creation and maintenance: Single center results
  7. Target Trial Framework
  8. Dialysis Catheter Tip Design and Dysfunction: An Unsolved Challenge
  9. Global variability of vascular and peritoneal access for chronic dialysis
  10. Dialysis Vascular Access and Critical Distal Ischemia
  11. Practice of dialysis access interventional nephrology procedures in the Asia‐Pacific region: Getting lay of the land
  12. Long-Term Dialysis Vascular Access in East Africa: Unique Challenges and Novel Solutions
  13. Global hemodialysis vascular access care: Three decades of evolution
  14. Dialysis Vascular Access Training: A Peruvian Experience
  15. Challenges with tunneled dialysis catheter placement with subcutaneous emphysema
  16. Therapeutic Advances in Diabetic Nephropathy
  17. The Sisyphean Task of Getting the Arteriovenous Fistula to Mature
  18. Calciphylaxis in uraemic and nonuraemic settings: clinical risk factors and histopathological findings
  19. Safety of Bedside Placement of Tunneled Hemodialysis Catheters in the Intensive Care Unit: Translating from the COVID-19 Experience
  20. Characterization of Patients With Type 2 Diabetes and Chronic Kidney Disease in a Large Integrated Health System
  21. Central Venous Catheters for Hemodialysis—the Myth and the Evidence
  22. Clinical relevance of abstruse transport phenomena in haemodialysis
  23. Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one
  24. Acute hemodialysis catheter follows the path of least resistance
  25. An Overlooked Link between IgA Nephropathy and Lithium Toxicity: A Case Report
  26. Tunneled femoral dialysis catheter: Practical pointers
  27. Peritoneal dialysis: Status report in South and South East Asia
  28. Safety of Bedside Placement of Tunneled Hemodialysis Catheters In The Intensive Care Unit: Translating From The Covid-19 Experience – Retrospective Single-Center Case Series
  29. Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
  30. New Devices and Technologies for Hemodialysis Vascular Access: A Review
  31. Salvage of the existing venotomy site and tunnel: Redeeming the “Fallen dialysis catheter”
  32. Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review
  33. Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia
  34. Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia
  35. The Production, Efficacy, and Safety of Machine-Generated Bicarbonate Solution for Continuous Venovenous Hemodialysis (CVVHD): The Cleveland Clinic Method
  36. Dialysis Vascular Access Training: A Nicaraguan Experience
  37. POS-211 SAFETY AND EFFICACY OF BEDSIDE PLACEMENT OF TUNNELED HEMODIALYSIS CATHETERS IN PATIENTS WITH COVID-19 IN THE INTENSIVE CARE UNIT
  38. POS-615 Reusing an existing tunnel and venotomy site following accidental loss of a tunneled dialysis catheter
  39. Post-traumatic thrombotic microangiopathy: What trauma surgeons need to know?
  40. Racial differences in the relationship between high-normal 25-hydroxy vitamin d and parathyroid hormone levels in early stage chronic kidney disease
  41. Outcomes Following Percutaneous Coronary Intervention in Renal Transplant Recipients: A Binational Collaborative Analysis
  42. Use of Point of Care Ultrasound in Access for Dialysis: Hemodialysis and Peritoneal Dialysis
  43. Workforce capacity for the care of patients with kidney failure across world countries and regions
  44. Covered Stents for Cephalic Arch Stenosis
  45. SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
  46. Aetiology, practice patterns and burden of end‐stage kidney disease in South Asia and South‐East Asia: A questionnaire‐based survey
  47. Safety of bedside placement of tunneled dialysis catheter in COVID-19 patients
  48. Strategic plan for integrated care of patients with kidney failure
  49. The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis
  50. International Society of Nephrology’s initiative on interventional nephrology minimum training and program-building standards in resource-limited countries
  51. The Hemodialysis Access Surveillance Controversy Continues
  52. COVID-19 and the kidney
  53. Vessel Preservation in Chronic Kidney Disease
  54. Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease
  55. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
  56. Endovascular Bypass for Thoracic Vein Occlusion: An Innovative Technique for Hemodialysis Vascular Access
  57. Buttonhole Cannulation of Arteriovenous Fistulas in the United States
  58. Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce
  59. Developing the ethical framework of end-stage kidney disease care: from practice to policy
  60. Serum magnesium, mortality and disease progression in chronic kidney disease
  61. Management of Acute Kidney Injury in the Setting of Acute Respiratory Distress Syndrome: Review Focusing on Ventilation and Fluid Management Strategies
  62. Metabolic Acidosis, Hyperkalemia, and Renal Unresponsiveness to Aldosterone Syndrome: Response to Treatment with Low-Potassium Diet
  63. Long-Term AVF Patency - Can we do better?
  64. Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals
  65. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  66. Global Health Training Opportunities in North American Nephrology Fellowships
  67. Innovations in vascular access for hemodialysis
  68. Increasing access to integrated ESKD care as part of universal health coverage
  69. Best Vascular Access in the Elderly: Time for Innovation?
  70. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop
  71. Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients
  72. Recognizing Obesity in Adult Hospitalized Patients: A Retrospective Cohort Study Assessing Rates of Documentation and Prevalence of Obesity
  73. Prevalence and Documentation Rates of Obesity in Hospitalized Patients: Results of a Retrospective Cohort Study
  74. A Simplified Approach to the Management of Hypercalcemia
  75. High Flow and volume overload: The saga continues
  76. Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology
  77. Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access
  78. Leadless pacemaker placement in a patient with chronic kidney disease: A strategy to preserve central veins
  79. Vascular access of last resort
  80. Prevalence of chronic kidney disease among patients undergoing transradial percutaneous coronary interventions
  81. Pregnancy and hemodialysis access: A case for patient satisfaction in favor of a tunneled dialysis catheter
  82. Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review
  83. Acquired cystic kidney disease and renal tumor
  84. Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations
  85. Contrast-Induced nephropathy: Pathophysiology, risk factors, and prevention
  86. Dialysis catheter: “Love–Hate Relationship”
  87. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens
  88. Ten commonly asked questions by general nephrologists regarding stent use in a vascular access
  89. Prize Orals
  90. Fundamentals of treating AVG pseudoaneurysm
  91. Role of cardiac rhythm device as an etiology for central venous stenosis in CKD patients
  92. Antithrombotic therapy in end-stage renal disease
  93. Nephrology Education and Continuing Education in Resource-Limited Settings
  94. SP583VASCULAR ACCESS OUTCOMES REPORTED IN RANDOMISED TRIALS CONDUCTED IN PATIENTS REQUIRING HAEMODIALYSIS: A SYSTEMATIC REVIEW
  95. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease
  96. Vascular Access Guidelines: Summary, Rationale, and Controversies
  97. Central Venous Access for Hemodialysis
  98. Contributors
  99. Arteriovenous Graft Peri-anastomotic Outflow Stenosis
  100. Equal work for unequal pay: the gender reimbursement gap for healthcare providers in the United States
  101. Lower Extremity Permanent Dialysis Vascular Access
  102. How Can the Complications of Central Vein Catheters Be Reduced?
  103. Encapsulating Peritoneal Sclerosis
  104. LEARNING FROM IMAGES Fundamental Mistake During Tunneled Hemodialysis Catheter (TDC) Removal
  105. Hemodialysis Access in the Elderly: Planning to Execution
  106. Pre-Access Creation Evaluation—Is Vein Mapping Enough?
  107. A global curriculum for training the next generation of nephrologists
  108. Nephrology Workforce
  109. LEARNING FROM IMAGES Frosty Man
  110. A Simplified Approach to the Diagnosis of Atypical HUS: Clinical Considerations and Practical Implications
  111. How is Arteriovenous Fistula Longevity Best Prolonged?
  112. Hyponatremia Etiology and Tolvaptan: Are we Optimally Targeting the Mechanism?
  113. Thrombocytopenia in ESRD Patients: Epidemiology, Mechanisms and Interventional Nephrology Perspective
  114. Elderly patients with CKD—dilemmas in dialysis therapy and vascular access
  115. Approach to an Arteriovenous Access with a Faint Thrill
  116. Approach to an Arteriovenous Access with Hyperpulsatile Pulse
  117. LEARNING FROM IMAGES - Guidewire Position as a Guide to the Appropriate Positioning of Dialysis Catheter
  118. Safety of Brachial Arteriogram using a 3-French Dilator to Evaluate Nonmaturing Arteriovenous Fistulae
  119. LEARNING FROM IMAGES - Perinephric Lymphoma
  120. LEARNING FROM IMAGES - Size Matters
  121. Continued Eculizumab Therapy for Persistent Atypical Hemolytic Uremic Syndrome
  122. Methemoglobinemia-Induced Acute Kidney Injury
  123. LEARNING FROM IMAGES - Hand Pain with Dialysis Access: Is it Always Steal Syndrome?
  124. Blood Pressure Recordings During Hemodialysis Access Interventions: Implications for Acute Management
  125. Mediastinal-Renal Syndrome: A Rare Manifestation of Granulomatosis with Polyangiitis
  126. Education in Vascular Access
  127. LEARNING FROM IMAGES - Oops!! Can we Prevent this Fundamental Mistake?
  128. Emergence of Interventional Nephrology in the Asia-Pacific Region – A Report from New Zealand
  129. Takayasu's Arteritis: An Uncommon Cause of Renal Artery Stenosis and Therapeutic Considerations
  130. Aneurysmal Dilatation of Dialysis Arteriovenous Access
  131. LEARNING FROM IMAGES - Staghorn Calculi
  132. LEARNING FROM IMAGES: Subclavian or Internal Jugular Tunneled Dialysis Catheter: Can we Divulge the Location?
  133. A Case of Pulmonary Hemorrhage and Renal Failure
  134. LEARNING FROM IMAGES - Vascular Extension from an Infiltrating Renal Tumor
  135. LEARNING FROM IMAGES - Renal Volume in Polycystic Kidney Disease
  136. Optimal Hemodialysis Vascular Access in the Elderly Patient
  137. Nephrology Education in the Electronic Era - A Case Based Review
  138. LEARNING FROM IMAGES - Dysfunctional Dialysis Catheter
  139. Diagnosis of Arteriovenous Fistula Dysfunction
  140. Endovascular Techniques for Dialysis Vascular Access
  141. Editorial - Interventional Nephrology: A Big Opportunity for a Big Problem
  142. Plasma Concentration of Galanin in Chronic Hemodialysis Patients
  143. Cannulating the hemodialysis access through a stent graft – is it advisable?
  144. Adiponectin-Deficiency Exaggerates Sepsis-Induced Microvascular Dysfunction in the Mouse Brain
  145. The Current State of Interventional Nephrology in India
  146. Dialysis Vascular Access Management by Interventional Nephrology Programs at University Medical Centers in the United States
  147. Editorial: The Issues Related to Hemodialysis Catheter Lock Prophylaxis with Recombinant Tissue Plasminogen Activator
  148. Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis
  149. A circuitous detour
  150. Hemodialysis Vascular Access Care in the United States: Closing Gaps in the Education of Patient Care Technicians
  151. Broken Clamp on a Cuffed Tunneled Catheter-Are All Catheters Equal?
  152. Placing the Tal Palindrome dialysis catheter with or without peel-away sheath
  153. Iatrogenic Graft to Vein Fistula (GVF) Formation Associated with Synthetic Arteriovenous Grafts
  154. Successful Models of Interventional Nephrology at Academic Medical Centers
  155. Nephrology “e” Learning Made “e” asier
  156. Obstacles for Clinical Monitoring in Hemodialysis Patients Because of Multiple Vascular Accesses
  157. Prophylactic Antibiotic for Tunneled Dialysis Catheters
  158. ASDIN: Patency Rates for Angioplasty in the Treatment of Pacemaker‐Induced Central Venous Stenosis in Hemodialysis Patients: Results of a Multi‐Center Study
  159. Central Vein Hardware: Cannot Live With It, Cannot Live Without It
  160. Fatal Lactic Acidosis Associated with Lymphoma, Interferon and Ribavirin§~!2008-08-13~!2008-11-12~!2008-12-12~!
  161. Correspondence: Vascular Access Conundrum
  162. Correspondence: Re: Vascular Access Conundrum
  163. ASDIN Clinical Case Focus: Timing of Secondary Arteriovenous Fistula Creation Avoids Tunneled Catheter Placement
  164. Retrospective Analysis of Catheter Recirculation in Prevalent Dialysis Patients
  165. Long-term outcomes of transposed basilic vein arteriovenous fistulae
  166. Managing Dialysis Catheter–Related Staphylococcus aureus Bacteremia
  167. Hemodialysis Grafts: On the Controversial Decision to Stent Venous Anastomotic Stenoses
  168. Aging veterans and the end-stage renal disease management dilemma in the millennium
  169. Non-Surgical Salvage of Thrombosed Arterio-Venous Fistulae: A Case Series and Review of the Literature
  170. Sheathless or 'over-the wire' technique for tunnelled cuffed catheter insertion
  171. Vasopressin-receptor antagonist therapy in patients with hyponatraemia
  172. STEROID-INDUCED LACTIC ACIDOSIS IN LYMPHOMA.
  173. Interventional Nephrology in a Federal Hospital: Economics of Health Care
  174. A large splenic cyst mimicking diabetic gastroparesis
  175. A large splenic cyst mimicking diabetic gastroparesis
  176. Marked hyperuricemia with acute renal failure: need to consider occult malignancy and spontaneous tumour lysis syndrome
  177. Detection of Occult Renovascular Disease in Unexplained Chronic Kidney Disease
  178. Curvularia Geniculata Fungal Peritonitis: A Case Report with Review of Literature
  179. Failing Heart, Famished Kidneys.
  180. A Large Splenic Cyst: “Incindentalocyst”
  181. Does treating obesity stabilize chronic kidney disease?
  182. Invasive and Innovative Nephrology
  183. Invasive and Innovative Nephrology
  184. 216 EFFECT OF DIALYSIS CATHETER DESIGN ON RECIRCULATION RATE:
  185. 248 ACUTE RENAL FAILURE DUE TO SPONTANEOUS TUMOR LYSIS SYNDROME
  186. 214 LYMPHOMA PRESENTING AS ACCELERATED HYPERTENSION AND RENAL FAILURE
  187. 205 SEVERE HYPERKALEMIA AND METABOLIC ACIDOSIS IN DIABETES: BEYOND KETOACIDOSIS
  188. 210 INTERLEUKIN-10 GENE POLYMORPHISMS MAY BE ASSOCIATED WITH ERYTHROPOIETIN RESISTANCE IN DIALYSIS PATIENTS:
  189. ACUTE RENAL FAILURE SECONDARY TO PEGYLATED INTERFERON ALPHA THERAPY
  190. Correspondence: Nephrology Education Clinic for Early Chronic Kidney Disease
  191. Nephrology Ethics: “No Dialysis” As a Treatment Option
  192. Is Dialysis Always Justified? Ethics and Economics
  193. American Society of Diagnostic and Interventional Nephrology Section Editor: Stephen Ash: Port Catheter Placement by Nephrologists in an Interventional Nephrology Training Program
  194. EFFICACY AND SAFETY OF TOTAL DOSE IRON DEXTRAN IN PREDIALYSIS POPULATION.
  195. CELIAC SPRUE AND RENAL CELL CARCINOMA: A UNIQUE ASSOCIATION.
  196. 348 EFFICACY AND SAFETY OF TOTAL DOSE IRON DEXTRAN IN PREDIALYSIS POPULATION.
  197. MODERN NEPHROLOGY: “ONE-STOP-SHOP” APPROACH.
  198. 112 MODERN NEPHROLOGY: “ONE-STOP-SHOP” APPROACH.
  199. 113 CELIAC SPRUE AND RENAL CELL CARCINOMA: A UNIQUE ASSOCIATION.
  200. Interventional nephrology in federal health care system
  201. Hyponatremia in Critically Ill Patients
  202. Does Abnormal Trace Element Metabolism Contribute to Dialysis Patient Morbidity?
  203. Diagnosis and Treatment of Tuberculosis in Hemodialysis and Renal Transplant Patients
  204. Ipsilateral deep venous thrombosis in renal transplant recipients: the need for prolonged anticoagulation